NIKKEI 225
29,683.09 +84.43 (+0.29%) HANG SENG
25,319.72 -330.36 (-1.29%) GOLD FUTURES
1,861.20 -0.20 (-0.01%) DOW
35,870.95 -60.10 (-0.17%) BTC-GBP
43,009.25 +2,203.66 (+5.40%) CMC Crypto 200
1,402.14 -65.80 (-4.48%)
Amplitude Surgical SA (0RAF.L)
| Previous close | 2.1300 |
| Open | 2.1200 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.1200 - 2.1200 |
| 52-week range | 2.1200 - 2.1200 |
| Volume | 314 |
| Avg. volume | N/A |
| Market cap | 133.626M |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amplitude Surgical Announces Its 2021-22 Financial Calendar
VALENCE, France, November 18, 2021--Regulatory News: Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) ("Amplitude" or the "Group"), French leader on the global surgical technology market for lower-limb orthopedics, announces its 2021-22.
- Business Wire
Amplitude Surgical – First quarter 2021-22: Sales of €20.2 million, -7.1% at constant exchange rates
VALENCE, France, November 18, 2021--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first quarter of its 2021-22 financial year.
- Business Wire
Amplitude Surgical – 2020-21 Annual Results: Sales of €95.5m and EBITDA of €20.6m
VALENCE, France, October 20, 2021--Regulatory News: Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans), a leading French player on the surgical technology market for lower-limb orthopedics, announces its 2020-21 annual results.
